Brand-name prescription drug pricing : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters.

Bibliographic Details
Corporate Author:	United States. Government Accountability Office
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]
Subjects:	Prescription pricing. Brand name products > Prices. Prescription pricing > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS121786

Description
Item Description:	Title from PDF title screen (GAO, viewed Apr. 27, 2010). "December 2009." "GAO-10-201." Electronic resource.
Physical Description:	1 online resource (ii, 35 pages)
Bibliography:	Includes bibliographical references.